John M. M. Raemaekers

机构：Radboud University Nijmegen, Radboud University Medical Center, European Organisation for Research and Treatment of Cancer

发表论文 197 篇 · 总被引 9411 次 · h-index 49

代表论文

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma (2015 · New England Journal of Medicine · 被引 639)
Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial (2017 · Journal of Clinical Oncology · 被引 540)
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium (2019 · Journal of Clinical Oncology · 被引 261)
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial (2018 · Blood · 被引 194)
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma (2023 · Journal of Clinical Oncology · 被引 59)
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium (2017 · Haematologica · 被引 50)